Intellia Therapeutics, Inc. — All Filings
683 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001517 | Mar 27, 2026 | — |
| 4 | 4 | 0001193125-26-088269 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-088260 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-088258 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-088254 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-088251 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-088241 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-088236 | Mar 3, 2026 | Mar 1, 2026 |
| 424B5 | 424B5 | 0001193125-26-085425 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001193125-26-084309 | Mar 2, 2026 | — |
| S-8 | S-8 | 0001193125-26-077385 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-076550 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-073456 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001999371-26-003032 | Feb 11, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-009584 | Feb 3, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000156 | Jan 30, 2026 | — |
| 8-K | 8-K | 0001193125-26-023387 | Jan 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-008307 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-006294 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006292 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006291 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006288 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006283 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006278 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006275 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006264 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-25-317551 | Dec 12, 2025 | Dec 11, 2025 |
| 144 | — | 0001969223-25-001077 | Dec 11, 2025 | — |
| SCHEDULE 13G | — | 0001999371-25-017496 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-274596 | Nov 10, 2025 | Nov 8, 2025 |
| 10-Q | 10-Q | 0001193125-25-269680 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269479 | Nov 6, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-106358 | Nov 4, 2025 | — |
| 8-K | 8-K | 0001193125-25-256378 | Oct 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-250757 | Oct 27, 2025 | — |
| 4 | 4 | 0001193125-25-230424 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | 4 | 0001193125-25-230420 | Oct 3, 2025 | Oct 1, 2025 |
| 8-K | 8-K | 0001193125-25-217484 | Sep 25, 2025 | — |
| 4 | 4 | 0000950170-25-110979 | Aug 22, 2025 | Aug 20, 2025 |
| 10-Q | 10-Q | 0000950170-25-104987 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104574 | Aug 7, 2025 | — |
| 4 | 4 | 0000950170-25-098774 | Jul 25, 2025 | Jul 23, 2025 |
| 4 | 4 | 0000950170-25-093852 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093844 | Jul 3, 2025 | Jul 2, 2025 |
| 4 | 4 | 0000950170-25-093302 | Jul 2, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-087887 | Jun 18, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0001193125-25-141087 | Jun 16, 2025 | Jun 15, 2025 |
| 4 | 4 | 0000950170-25-086287 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086277 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086271 | Jun 13, 2025 | Jun 11, 2025 |